The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

Our grey matter has always been a mystery, even to neurologists, but Professor Masud Husain says life-changing advances may ...

In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

This approval is considered a major breakthrough in treating acute pain without the need for opioid medication as reliance on such medications could lead to addiction. As per the Centers for Disease ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

Dr. Anna Lembke says that all that convenience and abundance is making us less happy, and there is plenty of research to back her up: In the developed world, we are lonelier, more anxious and more ...

AURORA, CO / ACCESS Newswire / January 31, 2025 / Exxel Pharma ("Exxel" or the "Company"), a pharmaceutical company dedicated ...

Whether you're shopping for a holistic health connoisseur or a fitness enthusiast or, our editors' favorite picks have you ...

The IPL provides a different ladder in terms of recognition.' 'If you do well, you will obviously get noticed and it enhances your selection into white-ball formats.' ...

The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ 2.75 Billion in 2024 and an impressive US$ 4.24 Billion by 2029. The ...